High prevalence of tuberculosis is expected to drive the growth of India Rifampicin market. According to TechSci Research report, “India Rifampicin Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule and Injection), By Route of Administration (Oral v/s Intravenous), By Distribution Channel (Online v/s Offline), By Application (Tuberculosis, Leprosy, Legionnaire’s Disease and